| Cat. No. |
Product Name |
Information |
| PC-28796 |
Vonafexor
FXR agonist
|
Vonafexor (EYP001) is a synthetic, orally active, non-steroidal, non-bile acid agonist of arnesoid X receptor (FXR), also inhibits HBV transcriptional activity, blocks c-Rel nuclear entry in MDSCs, induces sublethal damage of HBV-positive liver cancer cells. |
| PC-27234 |
HEC96719
FXR agonist
|
HEC96719 is a potent, selective tricyclic farnesoid X receptor (FXR) agonist with EC50 of 1.37 nM and 1.55 nM by TR-FRET and luciferase reporter assays, respectively. |
| PC-26702 |
PX20606
FXR agonist
|
PX20606 (PX-102) is a potent, selective FXR agonist with EC50 of 771 nM, 237 nM and 129 nM for mouse, rat, and human FXR in biochemical TR-FRET assays. |
| PC-26701 |
Fexaramine-3
FXR agonist
|
Fexaramine-3 (Fex-3, Fex3) is a potent, selective intestinal-restricted FXR agonist, significantly promotes the mRNA expression of BSEP and SHP and suppresses CYP7A1, all of which are the target genes of FXR. |
| PC-26301 |
Altenusin
FXR agonist
|
Altenusin (2076A) is a nonsteroidal fungal metabolite and potent, selective agonist of Farnesoid X receptor (FXR) with EC50 of 3.2 uM. |
| PC-25964 |
Linafexor
FXR agonist
|
Linafexor (CS0159) is a potent, selective and orally bioavailable agonist of farnesoid X receptor (FXR). |
| PC-24120 |
Danifexor
FXR agonist
|
Danifexor is a potent, selective farnesoid X receptor (FXR) agonist with EC50 of 50-500 nM, patent WO2021109712 A1 (Compound II). |
| PC-23132 |
BAR-2227
LIFR antagonist/FXR agonist
|
BAR-2227 (Dual FXR-LIFR modulator 3a) is a first-in-class hybrid leukemia inhibitory factor receptor (LIFR) inhibitor and Farnesoid X receptor (FXR) agonist with IC50 of 2.0 uM and EC50 of 3.2 uM respectively, protects against the development of acute liver fibrosis and inflammation. |
| PC-22169 |
F44-A13
FXR antagonist
|
F44-A13 is a highly selective farnesoid X receptor (FXR) antagonist with IC50 of 1.1 uM, with high selectivity over eleven other nuclear receptors. |
| PC-21879 |
ID166
FXR agonist
|
Lecufexor (D119031166, ID166) is a novel potent, selective farnesoid X receptor (FXR) agonist with EC50 of 3 nM and 5 nM in TR-FRET FXR co-activator assay and FXR reporter assay, respectively. |
| PC-20980 |
HPG1860
FXR agonist
|
HPG1860 is a potent, selective, nonbile acid full FXR agonist with EC50 of 5 nM and 18 nM in FR-FRET and luciferase assays, respectively. |
| PC-20979 |
MET409
FXR agonist
|
MET409 (MET-409) is a potent, selective farnesoid X receptor (FXR) agonist with EC50 of 16 nM (human FXR). |